FolA-conjugated siEG5 nanoparticles, designed by click-modification with DBCO-PEG-FolA, displayed extended tumor retention in L1210 tumor-bearing mice after intravenous application, with a knockdown of ~60% of target EG5 gene silencing [157]. This evidence concerns the gene KIF11 and neoplasm.